Sanofi-Aventis U.S. Llc
1 products tracked · names used in filings: Sanofi-Aventis U.S. Llc
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 09 Jul 2026🇺🇸 FDA approval
FDA approves Sarclisa Escena (isatuximab-irfc), a new medicine
Sanofi-Aventis U.S. Llc; BLA761445; New biologic; vial · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Sarclisa Escena isatuximab-irfc | Approved | 2026-07-09 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.